Satoshi Kuwabara

发表

Serum cytokine profiles in myasthenia gravis with anti-muscle-specific kinase antibodies

A. Uzawa, M. Yasuda, Y. Ozawa, 2023, Journal of Neuroimmunology.

Different responses to interferon beta‐1b treatment in patients with neuromyelitis optica and multiple sclerosis

M. Mori, A. Uzawa, S. Kuwabara, 2010, European journal of neurology.

Modulation of the kallikrein/kinin system by the angiotensin‐converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis

M. Mori, A. Uzawa, S. Kuwabara, 2014, Clinical and experimental immunology.

Dementia with Lewy bodies can be well‐differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity—a [11C]MP4A PET study

T. Suhara, M. Higuchi, M. Yamada, 2015, International journal of geriatric psychiatry.

Clinical features and outcomes of patients with muscle-specific kinase antibody-positive myasthenia gravis in Japan

Shigeaki Suzuki, A. Uzawa, K. Utsugisawa, 2023, Journal of Neuroimmunology.

Pelvic organ dysfunction is more prevalent and severe in MSA‐P compared to parkinson's disease

T. Uchiyama, T. Yamanishi, Tatsuya Yamamoto, 2011, Neurourology and urodynamics.

Effects of Denosumab and Bisphosphonates on Glucocorticoid-induced Osteoporosis in Patients with Neuroimmunological Disorders.

M. Mori, A. Uzawa, M. Yasuda, 2024, Internal medicine.

Serum antinuclear antibody may be associated with less severe disease activity in neuromyelitis optica

M. Mori, A. Uzawa, M. Muto, 2016, European journal of neurology.

Adequate tacrolimus concentration for myasthenia gravis treatment

A. Uzawa, S. Kuwabara, N. Kawaguchi, 2017, European journal of neurology.